Literature DB >> 12667755

Vesicle trafficking: pleasure and pain from SM genes.

Ruud F G Toonen1, Matthijs Verhage.   

Abstract

Most cells contain a variety of transport vesicles traveling to different destinations. Although many specific transport routes exist, the underlying molecular principles appear to be rather similar and conserved in evolution. It has become evident that formation of protein complexes named SNARE complexes between vesicle and target membrane is a central aspect of the final fusion reaction in many, if not all, routes and that SNARE complexes in different routes and species form in a similar manner. It is also evident that a second gene family, the Sec1/Munc18 genes (SM genes), plays a prominent role in vesicle trafficking. But, in contrast to the consensus and clarity about SNARE proteins, recent data on SM proteins in different systems produce an uncomfortable heterogeneity of ideas about their exact role, their site of action and their relation to SNARE proteins. This review examines whether a universal principle for the molecular function of SM genes exists and whether the divergence in SM gene function can be related to the unique characteristics of different transport routes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667755     DOI: 10.1016/s0962-8924(03)00031-x

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  101 in total

1.  rsly1 binding to syntaxin 5 is required for endoplasmic reticulum-to-Golgi transport but does not promote SNARE motif accessibility.

Authors:  Antionette L Williams; Sebastian Ehm; Noëlle C Jacobson; Dalu Xu; Jesse C Hay
Journal:  Mol Biol Cell       Date:  2003-10-17       Impact factor: 4.138

2.  Unconventional myosin Myo1c promotes membrane fusion in a regulated exocytic pathway.

Authors:  Avirup Bose; Stacey Robida; Paul S Furcinitti; Anil Chawla; Kevin Fogarty; Silvia Corvera; Michael P Czech
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

3.  Three-dimensional tracking of single secretory granules in live PC12 cells.

Authors:  Dongdong Li; Jun Xiong; Anlian Qu; Tao Xu
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

Review 4.  Formation, stabilisation and fusion of the readily releasable pool of secretory vesicles.

Authors:  Jakob Balslev Sørensen
Journal:  Pflugers Arch       Date:  2004-03-02       Impact factor: 3.657

5.  Low-resolution solution structures of Munc18:Syntaxin protein complexes indicate an open binding mode driven by the Syntaxin N-peptide.

Authors:  Michelle P Christie; Andrew E Whitten; Gordon J King; Shu-Hong Hu; Russell J Jarrott; Kai-En Chen; Anthony P Duff; Philip Callow; Brett M Collins; David E James; Jennifer L Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-05       Impact factor: 11.205

6.  Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size.

Authors:  Ruud F G Toonen; Keimpe Wierda; Michèle S Sons; Heidi de Wit; L Niels Cornelisse; Arjen Brussaard; Jaap J Plomp; Matthijs Verhage
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

Review 7.  MUNC-ing around with insulin action.

Authors:  David E James
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 8.  Rabs and their effectors: achieving specificity in membrane traffic.

Authors:  Bianka L Grosshans; Darinel Ortiz; Peter Novick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

9.  Early endosomal SNAREs form a structurally conserved SNARE complex and fuse liposomes with multiple topologies.

Authors:  Daniel Zwilling; Anna Cypionka; Wiebke H Pohl; Dirk Fasshauer; Peter J Walla; Markus C Wahl; Reinhard Jahn
Journal:  EMBO J       Date:  2006-12-07       Impact factor: 11.598

10.  Defects in synaptic vesicle docking in unc-18 mutants.

Authors:  Robby M Weimer; Janet E Richmond; Warren S Davis; Gayla Hadwiger; Michael L Nonet; Erik M Jorgensen
Journal:  Nat Neurosci       Date:  2003-09-14       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.